Ivana Pavik-Mezzour

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The use of low-density lipoprotein cholesterol (LDL-C)-lowering medications has led to a significant reduction of cardiovascular risk in both primary and secondary prevention. Statin therapy, one of the cornerstones for the prevention and treatment of cardiovascular disease (CVD), has been demonstrated to be effective in lowering LDL-C levels and in(More)
  • 1